Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2170360 | 0.84 | CA12 (0.42) | PPARAMEN1KMT2AGSTP1CA12 | |
| SCHEMBL15873588 | 0.80 | HRH3 (0.46) | LTA4HPPARAPPARGMEN1KMT2A | |
| SCHEMBL634910 | 0.79 | LTA4H (0.45) | LTA4HPPARAPPARGMEN1KMT2A | |
| SCHEMBL11012248 | 0.79 | MAOB (0.48) | HRH3 | |
| SCHEMBL3677826 | 0.79 | GSTP1 (0.55) | LTA4HMEN1KMT2AHRH3CYSLTR1 | |
| SCHEMBL23091403 | 0.79 | IDO1 (0.48) | LTA4HPPARAGSTP1CA12CA1 | |
| SCHEMBL8012112 | 0.79 | FFAR1 (0.50) | CA2TSHR | |
| SCHEMBL2641227 | 0.78 | LTA4H (0.47) | LTA4HMEN1KMT2APTPN1 | |
| SCHEMBL7773816 | 0.77 | TSHR (0.53) | PPARAPPARGCYSLTR1TSHR | |
| SCHEMBL26962314 | 0.76 | ADAM17 (0.47) | LTA4HPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024537-B2 | Compositions and methods for chemical synthesis | SEDERMA (FR) | 2024-07-02 | — | — | US | claimed |
| EP-3802554-B1 | METHOD FOR SOLUTION-PHASE PEPTIDE SYNTHESIS AND PROTECTING STRATEGIES THEREFORE | SEDERMA SA (FR) | 2023-12-13 | — | — | EP | claimed |
| EP-4251632-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | Sederma (FR) | 2023-10-04 | — | — | EP | claimed |
| WO-2022115825-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | GAP PEPTIDES, LLC (US) | 2022-06-02 | — | — | WO | claimed |
| US-20210170037-A1 | BRANCHED SUGAR ALCOHOL-BASED COMPOUNDS, AND COMPOSITIONS AND METHODS THEREOF | CELLMOSAIC INC (US) | 2021-06-10 | — | — | US | claimed |
| EP-3802554-A1 | METHOD FOR SOLUTION-PHASE PEPTIDE SYNTHESIS AND PROTECTING STRATEGIES THEREFORE | Gap Peptides LLC (US) | 2021-04-14 | — | — | EP | claimed |
| CN-112584871-A | Branched sugar alcohol-based compounds and compositions and methods thereof | 希默赛生物技术公司 | 2021-03-30 | — | — | CN | claimed |
| US-20210079036-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | GAP PEPTIDES LLC (US) | 2021-03-18 | — | — | US | claimed |
| EP-1945798-B1 | METHOD FOR DETERMINING THE CLEAVABILITY OF SUBSTRATES | FORSCHUNGSZENTRUM BORSTEL (DE) | 2013-05-22 | — | — | EP | claimed |
| US-20090258381-A1 | Methods for Determining the Cleavability of Substrates | FORSCHUNGSZENTRUM BORSTEL (DE) | 2009-10-15 | — | — | US | claimed |
| EP-1945798-A2 | METHODS FOR DETERMINING THE CLEAVABILITY OF SUBSTRATES | Forschungszentrum Borstel (DE) | 2008-07-23 | — | — | EP | claimed |
| WO-2007051605-A2 | METHODS FOR DETERMINING THE CLEAVABILITY OF SUBSTRATES | FORSCHUNGSZENTRUM BORSTEL (DE) | 2007-05-10 | — | — | WO | claimed |
| US-20050130228-A1 | Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form | H. LUNDBECK A/S (DK) | 2005-06-16 | — | — | US | claimed |
| WO-2004050686-A2 | PROCESS AND SUPPORTS FOR SYNTHESIS OF PEPTIDES COMPRISING A THIOESTER OR THIOACID | AVECIA LIMITED (GB) | 2004-06-17 | — | — | WO | claimed |
| US-20030138847-A1 | Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form | H. LUNDBECK A/S (DK) | 2003-07-24 | — | — | US | claimed |
| EP-1268050-A2 | DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM | H. Lundbeck A/S (DK) | 2003-01-02 | — | — | EP | claimed |
| WO-2001068598-A2 | DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM | H. LUNDBECK A/S (DK) | 2001-09-20 | — | — | WO | claimed |
| US-12024537-B2 | Compositions and methods for chemical synthesis | SEDERMA (FR) | 2024-07-02 | — | — | US | disclosed |
| EP-0277561-B1 | NEW ARGININE DERIVATIVE, PROCESS FOR THE PREPARATION THEREOF AND ITS USE IN PEPTIDE SYNTHESIS | ENIRICERCHE S.p.A. (IT) | 1992-04-15 | — | — | EP | disclosed |
| EP-0277561-A1 | New arginine derivative, process for the preparation thereof and its use in peptide synthesis | ENIRICERCHE S.p.A. (IT) | 1988-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170037-A1 | BRANCHED SUGAR ALCOHOL-BASED COMPOUNDS, AND COMPOSITIONS AND METHODS THEREOF | SIGLEC7, CD44, SIGLEC9 | LTA4H 3304/4885PPARA 1864/4885PPARG 2078/4885 |
| US-20090258381-A1 | Methods for Determining the Cleavability of Substrates | CTSF, ADAM17, ADAM10 | LTA4H 824/4885PPARA 4824/4885PPARG 4849/4885 |
| US-12024537-B2 | Compositions and methods for chemical synthesis | NGLY1, DNPEP, HM13 | LTA4H 1151/4885PPARA 4556/4885PPARG 4374/4885 |
| US-20210079036-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | NGLY1, DNPEP, HM13 | LTA4H 1151/4885PPARA 4556/4885PPARG 4374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.